Q2 Earnings Forecast for MacroGenics Issued By B. Riley
MacroGenics, Inc. (NASDAQ:MGNX – Free Report) – Investment analysts at B. Riley issued their Q2 2025 EPS estimates for shares of MacroGenics in a research report issued on Monday, May 19th. B. Riley analyst M. Mamtani anticipates that the biopharmaceutical company will earn ($0.49) per share for the quarter. B. Riley currently has a “Neutral” […]
MacroGenics, Inc. (NASDAQ:MGNX – Free Report) – Investment analysts at B. Riley issued their Q2 2025 EPS estimates for shares of MacroGenics in a research report issued on Monday, May 19th. B. Riley analyst M. Mamtani anticipates that the biopharmaceutical company will earn ($0.49) per share for the quarter. B. Riley currently has a “Neutral” […]
